USP33 and pachyonychia congenita: Taking together, our study found the positive loop between USP33 and TGF-β pathway which eventually accelerated the progression of PC, it may inspire researchers to develop therapeutics targeting the USP33-TGFβ positive loop and provide novel treatment options for PC.